NCT06128785Completed
Electroacupuncture (EA) Promotes Gastrointestinal Functional Recovery After Radical Colorectal Cancer Surgery
Electroacupuncture Promotes Gastrointestinal Functional Recovery After Radical Colorectal Cancer Surgery: a Multicenter Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 30 Sept 2026
Brief summary (registry, in English)
The goal of this clinical trial is to verify the efficacy of electroacupuncture in accelerating the recovery of gastrointestinal function after colorectal cancer surgery. The main questions it aims to answer are: * Whether electroacupuncture can accelerate the recovery of gastrointestinal function in patients after colorectal cancer surgery. * Whether electroacupuncture intervention is safe for postoperative colorectal cancer patients. Participants will be randomized into 3 groups: The conventional control group will receive postoperative rehydration and nutritional support, correction of acid-base imbalance and electrolyte disturbance, anti-infection, hemostasis and other symptomatic treatments. In the electroacupuncture group, acupuncture will be performed within 6 hours after surgery on the basis of the conventional control group. Acupoint: bilateral Hegu (LI4), Zhigou (SJ6), Zusanli (ST36), Shangjuxu (ST37). Both after obtaining Qi, and unilaterally connected to the electroacupuncture instrument for electrical stimulation, the current frequency is continuous wave 5 Hz, the intensity of stimulation was as the patient tolerated. From the patient's safe return to the ward until fourth day post-surgery, or until the occurrence of the first postoperative flatus, administer treatment every 12 ± 8 hours for 30 minutes per session. The sham acupuncture group will based on the conventional control group, using a blunt-tipped needle tip that do not pierce the adhesive pad.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 305 (actual)
- First submitted
- 4 Sept 2023
- Start date
- 6 Nov 2023
- Primary completion date
- 8 Feb 2026
- Lead sponsor
- Shanghai Yueyang Integrated Medicine Hospital
- Diseases
- Colorectal cancer
- NCT number
- NCT06128785
What you commit to
- Study type: Interventional
- Participants enrolled: 305
- From 6 Nov 2023 to the primary completion date, 8 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have participated or are participating in other clinical studies in the 3 months prior to enrollment;
- Patients with tumor infiltration requiring resection of other organs;
Other illness
- Patients with psychiatric disorders;
- Patients undergoing ileal diversion for rectal cancer;
Other
- Patients with severe malnutrition (NRS2002 score ≥ 3);
- Patients with total colectomy;
- Prophylactic fistulae. Anyone who meets any of the above criteria will be excluded from the study.
Who the study is looking for
- Surgical patients who meet the diagnostic criteria for colorectal cancer and require elective radical colorectal cancer surgery;
- 18 years old ≤ age ≤ 79 years old, with no restriction on gender;
- Understand, agree to participate in this study and sign the informed consent form;
- American society of Aneshesiologists (ASA) classification I to III.
Age in the registry: 18 years to 79 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai Yueyang Integrated Medicine Hospital Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.